Par Drugs And Chemicals Limited - Asset Resilience Ratio
Par Drugs And Chemicals Limited (PAR) has an Asset Resilience Ratio of 3.08% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Par Drugs And Chemicals Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Par Drugs And Chemicals Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Par Drugs And Chemicals Limited total assets.
Liquid Assets Composition Over Time
This chart breaks down Par Drugs And Chemicals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Par Drugs And Chemicals Limited (PAR) financial obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs31.31 Million | 3.08% |
| Total Liquid Assets | Rs31.31 Million | 3.08% |
Asset Resilience Insights
- Limited Liquidity: Par Drugs And Chemicals Limited maintains only 3.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Par Drugs And Chemicals Limited Industry Peers by Asset Resilience Ratio
Compare Par Drugs And Chemicals Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Kamada
TA:KMDA |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 11.60% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 4.31% |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723 |
Drug Manufacturers - Specialty & Generic | 1.01% |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL |
Drug Manufacturers - Specialty & Generic | 5.90% |
Annual Asset Resilience Ratio for Par Drugs And Chemicals Limited (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Par Drugs And Chemicals Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-03-31 | 0.00% | Rs1.00K ≈ $10.81 |
Rs1.02 Billion ≈ $10.99 Million |
-3.38pp |
| 2023-03-31 | 3.38% | Rs30.02 Million ≈ $324.61K |
Rs888.68 Million ≈ $9.61 Million |
+2.10pp |
| 2022-03-31 | 1.27% | Rs10.02 Million ≈ $108.32K |
Rs786.90 Million ≈ $8.51 Million |
+1.27pp |
| 2019-03-31 | 0.00% | Rs150.00 ≈ $1.62 |
Rs513.55 Million ≈ $5.55 Million |
-- |
About Par Drugs And Chemicals Limited
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more